Trading Signals: IOVA Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Iovance Biotherapeutics Inc)
| IOVA latest price $24.6900 (-4.97%) ($24.1000 - $25.2100) on Mon. Feb. 24, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.08% (three month average) | RSI | 70 | Latest Price | $24.6900(-4.97%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | IOVA advances 0.7% a day on average for past five trading days. | Weekly Trend | IOVA advances 3.7% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support IOVA advance at 0% a week (0% probability) IBB(49%) XBI(48%) ARKG(47%) IWO(44%) ARKK(43%) | Factors Impacting IOVA price | IOVA will decline at least -1.54% in a week (0% probabilities). VIXM(-28%) VXX(-16%) UUP(-10%) TLT(-2%) TBT(-1%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.54% (StdDev 3.08%) | Hourly BBV | 0 () | Intraday Trend | -1% | | | |
|
5 Day Moving Average | $24.91(-0.88%) | 10 Day Moving Average | $24.28(1.69%) | 20 Day Moving Average | $23.51(5.02%) | To recent high | -16% | To recent low | 14.1% | Market Cap | $3.615b | | | | Iovance Biotherapeutics, Inc. operates as a biotechnology company. The firm engages in the development and commercialization of novel cancer immunotherapy products. Its lead product candidate, LN-144 for metastatic melanoma, is an autologous adoptive cell therapy utilizing tumor-infiltrating lymphocytes, or TIL, which are T cells derived from patients' tumors. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA. |